ASXL3 De Novo Variant-Related Neurodevelopmental Disorder Presenting as Dystonic Cerebral Palsy

Neuropediatrics. 2022 Oct;53(5):361-365. doi: 10.1055/s-0042-1750721. Epub 2022 Jul 21.

Abstract

ASXL3 loss-of-function variants represent a well-established cause of Bainbridge-Ropers syndrome, a syndromic neurodevelopmental disorder with intellectual and motor disabilities. Although a recent large-scale genomics-based study has suggested an association between ASXL3 variation and cerebral palsy, there have been no detailed case descriptions. We report, here, a female individual with a de novo pathogenic c.1210C > T, p.Gln404* nonsense variant in ASXL3, identified within the frame of an ongoing research project applying trio whole-exome sequencing to the diagnosis of dystonic cerebral palsy. The patient presented with a mixture of infantile-onset limb/trunk dystonic postures and secondarily evolving distal spastic contractures, in addition to more typical features of ASXL3-related diseases such as severe feeding issues, intellectual disability, speech impairment, and facial dysmorphic abnormalities. Our case study confirms a role for ASXL3 pathogenic variants in the etiology of cerebral-palsy phenotypes and indicates that dystonic features can be part of the clinical spectrum in Bainbridge-Ropers syndrome. ASXL3 should be added to target-gene lists used for molecular evaluation of cerebral palsy.

Publication types

  • Case Reports

MeSH terms

  • Cerebral Palsy* / complications
  • Cerebral Palsy* / diagnosis
  • Cerebral Palsy* / genetics
  • Child
  • Developmental Disabilities / complications
  • Developmental Disabilities / diagnosis
  • Female
  • Humans
  • Intellectual Disability* / genetics
  • Phenotype
  • Syndrome
  • Transcription Factors / genetics

Substances

  • ASXL3 protein, human
  • Transcription Factors